Safety and Efficacy of Losmapimod in Facioscapulohumeral Muscular Dystrophy (redux4): a Randomised, Double-Blind, Placebo-Controlled Phase 2b Trial
Rabi Tawil,Kathryn R. Wagner,Johanna Hamel,Doris G. Leung,Jeffrey M. Statland,Leo H. Wang,Angela Genge,Sabrina Sacconi,Hanns Lochmueller,David Reyes-Leiva,Jordi Diaz-Manera,Jorge Alonso-Perez,Nuria Muelas,Juan J. Vilchez,Alan Pestronk,Summer Gibson,Namita A. Goyal,Lawrence J. Hayward,Nicholas Johnson,Samantha LoRusso,Miriam Freimer,Perry B. Shieh,S. H. Subramony,Baziel van Engelen,Joost Kools,Olof Dahlqvist Leinhard,Per Widholm, Christopher Morabito, Christopher M. Moxham,Diego Cadavid,Michelle L. Mellion,Adefowope Odueyungbo,William G. Tracewell,Anthony Accorsi,Lucienne Ronco, Robert J. Gould,Jennifer Shoskes,Luis Alejandro Rojas,John G. Jiang The Lancet Neurology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper